.svg){kind=small}
Discover opportunities months before the RFP drops
Learn more →Discover opportunities months before the RFP drops
Learn more →Retrieving RFP details
Starbridge can help you:
Pain points mentioned in board meetings and strategic plans
Instantly outline and draft all requirements
Bring in your USPs and exploit competitor gaps
Starbridge can help you:
Get ahead of RFPs — target accounts planning budget or ending contracts soon
Accounts with contract expirations, meetings mentioning your product, grants, budget changes and more
Starbridge.ai books 30 - 40% of leads into meetings
Premium
Access the largest public sector contact database
Premium
Get complete source documentation & analysis
Pharmaceuticals: Fenofibrate Camphor Menthol Methyl Salicylate Patches Sevelamer Carbonate Acamprosate Zolpidem Tartrate Sumatriptan Adapalene Mesalamine Clindamycin Clomiphene Citrate VA must procure foreign-made pharmaceuticals to meet patient care needs.
Starbridge can help you:
Pain points mentioned in board meetings and strategic plans
Instantly outline and draft all requirements
Bring in your USPs and exploit competitor gaps
Starbridge can help you:
Get ahead of RFPs — target accounts planning budget or ending contracts soon
Accounts with contract expirations, meetings mentioning your product, grants, budget changes and more
Starbridge.ai books 30 - 40% of leads into meetings
The Department of Veterans Affairs published a Special Notice inviting comments on a Buy American domestic nonavailability waiver determination for 10 specific pharmaceutical products that VA found not to be available domestically in sufficient quantity or quality. VA plans to use a single streamlined nonavailability waiver determination for FY2026 procurements of these products to improve procurement efficiency and ensure timely access to pharmaceuticals for patient care. Comments are requested and will not bind the VA to any procurement action; responses are due by February 4, 2026.
Posted Date
Jan 20, 2026
Due Date
Feb 4, 2026
Release: Jan 20, 2026
Close: Feb 4, 2026
The Department of Veterans Affairs published a Special Notice inviting comments on a Buy American domestic nonavailability waiver determination for 10 specific pharmaceutical products that VA found not to be available domestically in sufficient quantity or quality. VA plans to use a single streamlined nonavailability waiver determination for FY2026 procurements of these products to improve procurement efficiency and ensure timely access to pharmaceuticals for patient care. Comments are requested and will not bind the VA to any procurement action; responses are due by February 4, 2026.
AvailableFy2024 buy american statute domestic nonavailability waiver actions.
Posted Date
Jan 31, 2025
Due Date
Jan 30, 2026
Release: Jan 31, 2025
Close: Jan 30, 2026
Fy2024 buy american statute domestic nonavailability waiver actions.
AvailableVeterinary pharmaceuticals and supplies.
Posted Date
Jan 12, 2026
Due Date
Jan 28, 2026
Release: Jan 12, 2026
Close: Jan 28, 2026
Veterinary pharmaceuticals and supplies.
AvailableSupply and delivery of pharmaceuticals and otc products.
Posted Date
Jan 20, 2026
Due Date
Mar 26, 2026
Release: Jan 20, 2026
Close: Mar 26, 2026
Supply and delivery of pharmaceuticals and otc products.
AvailableSurface intent from meeting minutes, budgets, and contract expirations. Influence RFP requirements before competitors ever see them.
See your top 10 upcoming opportunities on a demo →Premium
Access the largest public sector contact database
Premium
Get complete source documentation & analysis